Two studies led by researchers at the NYU School of Global Public Health find both geographic differences and personal factors that shape where people might seek help during mental health crises.

The latest issues of three American Psychiatric Association journals (The American Journal of Psychiatry, Psychiatric Services, American Journal of Psychotherapy, and Psychiatric Research and Clinical Practice) are now available online. 

A groundbreaking new review comprehensively synthesizes the latest developments in next-generation chimeric antigen receptor T cell (CAR-T) therapies, highlighting key preclinical and clinical breakthroughs in the treatment of lymphoma. The article examines barriers to CAR-T efficacy and provides an in-depth analysis of innovative strategies, including multi-specific CAR, T cells redirected for universal cytokine-mediated killing (TRUCKs), switch receptor CAR, safety switch/suicide system, and in vivo CAR-T cells. With a special focus on the role of epigenetics and metabolism in CAR-T cell exhaustion, the review offers valuable insights and future directions for advancing CAR-T immunotherapy.

A new study finds that preteens with addictive patterns of social media, video games, or mobile phones use are more likely to experience worse mental health and suicidal thoughts and behaviors. 

About The Study: This study identified distinct trajectories of addictive use of social media, mobile phones, and video games from childhood to early adolescence and found links to suicidal behaviors, suicidal ideation, and worse mental health outcomes. High or increasing addictive use trajectories were common. Addictive screen use trajectories warrant further study regarding potential use for clinical evaluation of risk and for the design and testing of interventions to improve youth mental health.

New research found that youth who become increasingly addicted to social media, mobile phones or video games are at greater risk of suicidal thoughts, suicide attempts and emotional or behavioral issues. The study, published June 18 in JAMA, was led by researchers at Weill Cornell Medicine, Columbia University and University of California, Berkeley.